GlassScriptPhysician profile
Fred J Delucia
NPI 1225299175
$7,666.52
in general payments reported to CMS, 2019-2025
14 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $54.03 · 2021: $278 · 2022: $1,877 · 2023: $1,241 · 2024: $1,652 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,095 · Travel and Lodging: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,094.86 |
| Travel and Lodging | $1,352.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,682.39 | 2019-2025 | Augment Injectable, Allowrap, Citrefix |
| Arthrex, INC. | $2,545.38 | 2022-2024 | |
| Gotham Surgical Solutions & Devices, INC. | $650.94 | 2023-2024 | |
| Kerecis Limited | $373.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Atricure, INC. | $334.83 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Treace Medical Concepts, INC. | $296.51 | 2024-2025 | |
| Paragon 28, INC. | $281.89 | 2021-2025 | Portfolio, R3flex |
| Smith+Nephew, INC. | $136.04 | 2019-2023 | Collagenase Santyl |
| Bioventus LLC | $135.27 | 2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $113.61 | 2019 | |
| Djo, LLC | $53.00 | 2024 | Cmf |
| Averitas Pharma INC. | $26.95 | 2023 | Qutenza |
| Ibsa Pharma INC. | $20.01 | 2024 | Licart, Tirosint |
| Abbvie INC. | $16.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Delucia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.